VERTEX PHARMACEUTICALS INC / MA Quarterly Common Stock, Shares, Outstanding from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vertex Pharmaceuticals Inc / Ma quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2010 to Q2 2024.
  • Vertex Pharmaceuticals Inc / Ma Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 258M shares, a 0.09% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 258M +223K +0.09% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 258M +786K +0.31% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 258M +684K +0.27% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 258M +1.18M +0.46% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 258M +1.77M +0.69% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 258M +1.93M +0.76% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 257M +2.53M +1% Dec 31, 2022 10-K 2024-02-15
Q3 2022 257M +440K +0.17% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 256M -3.09M -1.19% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 256M -3.25M -1.26% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 254M -5.41M -2.08% Dec 31, 2021 10-K 2023-02-10
Q3 2021 256M -3.97M -1.53% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 259M -1.01M -0.39% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 259M -250K -0.1% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 260M +897K +0.35% Dec 31, 2020 10-K 2022-02-09
Q3 2020 260M +2.91M +1.13% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 260M +3.45M +1.35% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 259M +2.73M +1.06% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 259M +3.82M +1.5% Dec 31, 2019 10-K 2021-02-11
Q3 2019 257M +1.65M +0.65% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 257M +1.79M +0.7% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 256M +1.48M +0.58% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 255M +1.92M +0.76% Dec 31, 2018 10-K 2020-02-13
Q3 2018 256M +2.93M +1.16% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 255M +4.11M +1.64% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 255M +5.98M +2.4% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 253M +4.95M +2% Dec 31, 2017 10-K 2019-02-13
Q3 2017 253M +4.65M +1.88% Sep 30, 2017 10-Q 2017-10-30
Q2 2017 251M +3.07M +1.24% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 249M +1.6M +0.65% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 248M +1.99M +0.81% Dec 31, 2016 10-K 2018-02-15
Q3 2016 248M +2.38M +0.97% Sep 30, 2016 10-Q 2016-10-31
Q2 2016 248M +3.36M +1.38% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 247M +3.71M +1.52% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 246M +4.54M +1.88% Dec 31, 2015 10-K 2017-02-23
Q3 2015 246M +5.41M +2.25% Sep 30, 2015 10-Q 2015-10-30
Q2 2015 244M +7.01M +2.95% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 244M +7.38M +3.12% Mar 31, 2015 10-Q 2015-05-04
Q4 2014 242M +7.98M +3.41% Dec 31, 2014 10-K 2016-02-16
Q3 2014 240M +6.65M +2.85% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 237M Jun 30, 2014 10-Q 2014-07-31
Q1 2014 236M +17.5M +8.03% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 234M +16.5M +7.6% Dec 31, 2013 10-K 2015-02-13
Q3 2013 234M +17.3M +7.97% Sep 30, 2013 10-Q 2013-11-07
Q1 2013 219M +7.79M +3.69% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 217M +7.98M +3.81% Dec 31, 2012 10-K 2014-02-11
Q3 2012 216M +7.88M +3.78% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 215M +7.96M +3.84% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 211M +5.41M +2.63% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 209M +5.78M +2.84% Dec 31, 2011 10-K 2013-03-01
Q3 2011 208M +5.36M +2.64% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 207M +4.94M +2.44% Jun 30, 2011 10-Q 2011-08-09
Q1 2011 205M +3.34M +1.65% Mar 31, 2011 10-Q 2011-05-06
Q4 2010 204M Dec 31, 2010 10-K 2012-02-22
Q3 2010 203M Sep 30, 2010 10-Q 2010-10-28
Q2 2010 203M Jun 30, 2010 10-Q 2010-08-03
Q1 2010 202M Mar 31, 2010 10-Q 2010-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.